Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

NCT04181476 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04181476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04181476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects
Lead sponsor
Henry Ford Health System
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 5, 2019
Completion date
June 30, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sun damaged skin